Summarize the case(s) and the innovation that was applied
Concise literature review of the clinical problem
Explicitly state the innovation tested or what innovation will arise from the work presented
Patient Presentation, Etiology & Diagnosis
Details regarding 10 or fewer patients
Give patient’s chief complaint, etiology of the chief complaint, prioritized problem list and diagnosis
Provide supporting information as needed
Treatment Objectives, Plans & Applied Innovation
Describe treatment objectives and plans
Detailed description of applied innovation
Treatment Progress, Outcome & Innovation
Detail treatment plan, progress & retention with an emphasis on how the innovation was applied
List all contributors who did not meet our Authorship Criteria and their role in the study
Funding & Conflict Of Interest
List all sources of funding used for the study
List any Conflict(s) of Interest
List all references cited in the order they appear in the text
See Reference Page for details
Author Instructions : Applied Innovation Case Report
Concise title should include a concise description of the case(s) and innovation
Full names, institutional addresses and email addresses for all authors
If a collaboration group is to be listed as an author, list the Group name as an author. If you would like the names of the individual members of the Group to be searchable through their individual PubMed records, please include this information in the “Acknowledgements” section in accordance with the instructions below.
Indicate the corresponding author
Three to ten keywords representing the main content of the article
List Of Abbreviations
If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided.
The abstract should not exceed 350 words. Minimize the use of abbreviations and do not cite references in the abstract.
The abstract should be unstructured and summarizes the case(s) and the innovation that was applied.
This section must be a concise, yet detailed, review of the literature with an emphasis on what is not known about the clinical problem and how this justifies your study.
Explicitly state the innovation being tested or what innovation will arise from the work presented.
Patient Presentation, Etiology And Diagnosis
The Applied Innovation Case Report should discuss 10 or fewer patients. For reports involving only one patient, provide a complete description of the patient, his/her chief complaint, etiology of the chief complaint, complete prioritized problem list and diagnosis. Provide any supporting information needed to confirm these statements.
For reports involving more than one patient, describe the clinical problem all patients share, their chief complaint, its etiology, a complete prioritized problem list and diagnosis. Provide any supporting information needed to confirm these statements.
Treatment Objectives, Possible Treatment Plans, And Applied Innovation Tested
Provide a detailed description of the treatment objectives and all major possible treatment plans (including a retention plan). “No treatment” is not considered a treatment option.
Describe in detail the applied innovation to be used in the case. Include a complete description of the appliance or protocol, if none is available elsewhere.
State which treatment plan was used and describe in detail the sequential steps taken during treatment. Supporting clinical data of the treatment progress is required. Emphasis should be placed on how the innovation used in the case was applied.
Describe in detail the treatment outcome with an emphasis on how the innovation improved the treatment. Supporting clinical data is required. Superimpositions are not required, but may be included if they support the authors’ conclusions regarding treatment outcome.
Applied Innovation Case Discussion
Use this section to discuss all aspects of the case, with an emphasis on the innovation used and how the course of treatment and treatment outcome were improved.
All funding sources for the research reported must be declared. The role of the funding body in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript must be declared.
Acknowledge anyone who contributed to the article, but fails to meet our Authorship Criteria, including anyone who provided professional writing services or materials.
Authors should obtain permission to acknowledge from all those mentioned in this section.
GROUP AUTHORSHIP: if you would like the names of individual members of a collaboration or consortium to be searchable through PubMed, please ensure that the title of the collaboration or consortium is included on the Title Page, is entered into the ScholarOne Manuscript submission system and list the authors’ names as the last paragraph of the Acknowledgements. Please format the author’s names as follows:
First Name, Middle initial(s) (optional), Last Name (Institution and/or Country, optional).
Example: Catherine M. Anderson, Charles R. Granhold (US University, FL), E. Raphael Landen (Canada), Marion A. Smith-Thompson (EU University, Austria)
Please note that individual names may not be present in the PubMed record at the time a published article is initially included in PubMed as it takes PubMed additional time to code this information.